Back to analysis

KMT2D Gene Function

Lysine Methyltransferase 2D

ProteinCurated

Overview

KMT2D is a chromatin methyltransferase associated with enhancer H3K4 methylation. Loss-of-function alterations can disturb enhancer activity and lineage programmes and are recurrent in lymphoid malignancies and several solid tumours.

Read the epigenetics and chromatin topic guide

Molecular Mechanism

Detailed mechanism data is not yet available for KMT2D.

Key Pathways

  • ·H3K4 methylation
  • ·Enhancer regulation
  • ·Chromatin organisation

Disease Associations

  • ·Follicular lymphoma
  • ·Diffuse large B-cell lymphoma
  • ·Kabuki syndrome
  • ·Solid tumours

Functional Partners

KMT2CEZH2SMARCB1TET2DNMT3A

Common Questions About KMT2D

What does KMT2D do?

KMT2D participates in H3K4 methylation, Enhancer regulation, Chromatin organisation. KMT2D is a chromatin methyltransferase associated with enhancer H3K4 methylation. Loss-of-function alterations can disturb enhancer activity and lineage programmes and are recurrent in lymphoid malignancies and several solid tumours.

Why is KMT2D relevant to cancer research?

Its reported relevance includes Follicular lymphoma, Diffuse large B-cell lymphoma, Kabuki syndrome. The exact alteration, assay and disease context determine what a result can support.

Answers are based on peer-reviewed literature from PubMed and curated gene databases. Read our complete guide to gene function →